Fludarabine and risk of hepatitis B virus reactivation in chronic lymphocytic leukemia
Open Access
- 15 June 2000
- journal article
- letter
- Published by Wiley in American Journal of Hematology
- Vol. 64 (3) , 233-234
- https://doi.org/10.1002/1096-8652(200007)64:3<233::aid-ajh21>3.0.co;2-w
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Lamivudine Therapy for Chemotherapy-Induced Reactivation of Hepatitis B Virus InfectionAmerican Journal of Gastroenterology, 1999
- Clinical aspects of hepatitis B virus infectionThe Lancet, 1993
- Severe immunodeficiency in patients treated with fludarabine monophosphateEuropean Journal of Haematology, 1993
- Acute hepatic injury after the withdrawal of immunosuppressive chemotherapy in patients with hepatitis BCancer, 1990
- Phase II trial of recombinant leukocyte A interferon in patients with advanced chronic lymphocytic leukemiaThe American Journal of Medicine, 1985
- SUBACUTE AND CHRONIC ACTIVE HEPATITIS AFTER WITHDRAWAL OF CHEMOTHERAPYThe Lancet, 1975